9 Supported by research
Approximately 1 in 5,000 people rupture their Achilles tendon.
"I think one in 5,000 people rupture their Achilles." (said at 0:07:40)
An incidence of 1 in 5,000 individuals corresponds to an annual incidence rate of 20 per 100,000 person-years (0.02% per year). A comprehensive systematic review and meta-analysis of 28 population-based registry studies covering over 630 million person-years found a pooled global incidence of 15.7 per 100,000 person-years, with modern rates ranging from approximately 18 to 32 per 100,000 person-years depending on the region and year. Thus, the stated figure accurately reflects the annual population incidence of acute Achilles tendon ruptures.
- supports: The epidemiology and trends in management of acute Achilles tendon ruptures in Ontario, Ca… (The bone & joint journal 2017) · cited 140x in the literature
"A total of 27 607 patients (median age, 44 years; interquartile range 26 to 62; 66.5% male) sustained an AATR. The annual IDR increased from 18.0 to 29.3 per 100 000 person-years between 2003 and 2013." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Incidence, Temporal Trends, and Surgical Shift of Achilles Tendon Rupture: A Systematic Re… (Sports medicine (Auckland, N.Z.) 2026) · cited 4x in the literature
"Twenty-eight studies reporting Achilles tendon ruptures from 1950 to 2022 were included, representing over 630 million individuals and 568,000 Achilles tendon rupture cases. The pooled global incidence was 15.7 per 100,000 person-years, spanning from 6.1 in 1979 to 31.1 per 100,000 person-years in 2021, with an average annual increase of 2.7% (95% confidence interval 2.0-3.3%)." (abstract, results, passage verified)
pubmedfull study (doi)
95% of Americans do not consume enough dietary fiber.
"Well, it turns out that 95% of Americans don't get enough of it" (said at 0:24:10)
Nationally representative dietary data in the United States (such as from the National Health and Nutrition Examination Survey, NHANES) consistently demonstrate that only approximately 5% of the population meets the recommended Adequate Intake for dietary fiber, meaning roughly 95% of Americans fail to consume enough fiber.
Platypuses possess venom.
"platypuses are like freak alien otters. Also cute but have weird venom." (said at 0:41:45)
Male platypuses (Ornithorhynchus anatinus) possess a specialized crural venom system consisting of crural glands in the upper thigh connected via ducts to calcaneus spurs on their hind limbs. The venom contains a complex cocktail of unique proteins and peptides, including defensin-like peptides, C-type natriuretic peptides, and other novel toxins that are primarily produced seasonally during the breeding season.
Platypuses lay eggs.
"They also lay eggs, but they're kind of mammally as well." (said at 0:41:51)
The platypus (Ornithorhynchus anatinus) is a monotreme, an order of extant mammals that reproduce by laying eggs (oviparous reproduction) while possessing mammalian traits such as lactation and fur.
One scoop of AG1 contains 75 vitamins, minerals, probiotics, and whole-food sourced ingredients.
"One scoop contains 75 vitamins, minerals, probiotics, and whole-food sourced ingredients in a single daily drink." (said at 0:58:44)
The statement accurately reflects the formulation of AG1 (Athletic Greens), a commercial dietary supplement formulated as a single daily powdered drink combining 75 ingredients categorized across vitamins, minerals, probiotics, and whole-food sourced phytonutrient complexes. Published clinical trials investigating the supplement confirm its composition as a multi-ingredient formulation containing vitamins, minerals, probiotics, and plant-derived phytochemicals.
- supports: Effect of AG1 ® supplementation on nutritional adequacy and gut microbial composition… (Frontiers in nutrition 2026)
"Dietary supplements that combine vitamins, minerals, phytonutrients, prebiotics, and probiotics have gained popularity among health-oriented consumers seeking convenient ways to fill nutritional gaps and support gut health." (abstract, background, passage verified)
pubmedfull study (doi) - supports: Absorption kinetics of vitamins and minerals from a novel nutritional product in physicall… (Frontiers in nutrition 2026)
"This clinical trial assessed the acute absorption phase of key micronutrients in AG1, a comprehensive nutritional supplement containing vitamins, minerals, probiotics, and phytochemicals." (abstract, results, passage verified)
pubmedfull study (doi)
Breath tests for SIBO can determine whether the overgrowth is hydrogen-based or methane-based.
"You'll get your breath test back. It'll tell you whether it's whatever it is, fucking hydrogen-based or methane-based or whatever, and then just go through the standard process." (said at 1:23:24)
Breath testing for small intestinal bacterial overgrowth (SIBO) and intestinal methanogen overgrowth (IMO) measures exhaled concentrations of both hydrogen (H2) and methane (CH4) following the ingestion of a carbohydrate substrate such as glucose or lactulose. According to the North American Consensus guidelines for breath testing in gastrointestinal disorders, a rise in hydrogen of ≥20 ppm by 90 minutes defines a hydrogen-positive test, whereas a methane concentration of ≥10 ppm at any point during testing defines a methane-positive test.
SIBO is typically treated using an antibiotic protocol.
"SIBO's relatively easy to treat. I think it's kind of linear... follow the doctor's advice, do the antibiotics, and then see how you are on the other side of it." (said at 1:23:34)
Clinical guidelines and systematic reviews confirm that antibiotic therapy (most commonly the nonabsorbable antibiotic rifaximin) is the standard and primary approach to treating small intestinal bacterial overgrowth (SIBO). Meta-analyses of clinical trials demonstrate that antibiotic protocols achieve significantly higher breath test normalization and symptom improvement compared with placebo, although clinical practice guidelines note that addressing underlying causes is also necessary due to risk of recurrence.
Thymosin alpha-1 provides immune system support.
"immune support with the Thymosin Alpha" (said at 1:40:05)
Thymosin alpha-1 (Tα1) is a 28-amino-acid peptide naturally produced by the thymus gland that functions as an immunomodulatory agent. A substantial body of preclinical and clinical literature, including randomized controlled trials and systematic reviews, demonstrates that thymosin alpha-1 modulates immune function by stimulating T-cell differentiation, enhancing antigen presentation, regulating lymphocyte subsets (such as CD4+ and CD8+ T cells), and balancing inflammatory cytokine production across various clinical contexts, including severe infections, sepsis, and liver disease.
- supports: The efficacy of thymosin α1 as immunomodulatory treatment for sepsis: a systematic r… (BMC infectious diseases 2016) · cited 52x in the literature
"As to the immunological indicators, the level of HLA-DR were increased by Tα1 (SMD 1.23, 95 % CI 0.28 to 2.18, p = 0.01) according to the pooled analysis of 8 studies involving 721 patients. Lymphocyte subsets CD3, CD4 and cytokines IL-6, IL-10 and TNF-α were also beneficially affected by Tα1 treatment." (abstract, results)
pubmedfull study (doi) - supports: Aging and Thymosin Alpha-1. (International journal of molecular sciences 2025)
"Thymosin alpha-1 (Tα1), a peptide hormone produced by the thymus, exhibits potent immunomodulatory, anti-inflammatory, and antioxidant properties. It helps restore immune function by stimulating T-cell differentiation, enhancing thymic output, and modulating dendritic cell and macrophage activity." (abstract)
pubmedfull study (doi)
SS-31 (elamipretide) provides mitochondrial support.
"and then mitochondrial support with the SS-31 because I'm tired all the time." (said at 1:40:08)
SS-31 (also known as elamipretide, MTP-131, or Bendavia) is a mitochondria-targeted tetrapeptide specifically developed to support mitochondrial function. It selectively binds to cardiolipin on the inner mitochondrial membrane, stabilizing cristae architecture, optimizing electron transport chain efficiency, promoting adenosine triphosphate (ATP) synthesis, and decreasing excessive reactive oxygen species production across extensive preclinical and clinical studies.
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.